mAbSolution IVS: Financial statements 2017
CVR: 36893729
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
mAbSolution IVS (CVR 36893729) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -13,668 and a net result of DKK -13,668 compared with DKK -7,612 the year before. Equity in the 2017 report amounted to DKK -33,920.
- Gross Profit
- DKK -13,668
- Profit/Loss
- DKK -13,668
- Equity
- DKK -33,920
- Total Assets
- DKK 50,720
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -14 t. | -14 t. | -34 t. | - |
| 2016 | - | -8 t. | -8 t. | -10 t. | - |
Keep an eye on mAbSolution IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of June 29, 2017, Jørgen Søberg Petersen is registered as director of mAbSolution IVS.
As of June 29, 2017, Jørgen Søberg Petersen is registered as chairman of mAbSolution IVS.
As of June 29, 2017, Jørgen Søberg Petersen has stepped down as chairman of mAbSolution IVS.
MAbSolution IVS has published its annual report for 2016. Gross profit came to DKK -7,600, and the net result was DKK -7,612.
About mAbSolution IVS
mAbSolution IVS was a Danish company of the type Iværksætterselskab based in Kgs. Lyngby, founded in 2015 and dissolved in 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2017, the company reported a gross profit of DKK -13,668 and a net result of DKK -13,668 compared with DKK -7,612 the year before. Equity in the 2017 report amounted to DKK -33,920.